Thermo Fisher Scientific INC (TMO) Holding Has Increased by Pictet Asset Management Ltd

Thermo Fisher Scientific Inc. (NYSE:TMO) LogoInvestors sentiment increased to 1.08 in 2018 Q2. Its up 0.22, from 0.86 in 2018Q1. It increased, as 43 investors sold TMO shares while 378 reduced holdings. 100 funds opened positions while 356 raised stakes. 332.19 million shares or 0.06% more from 331.98 million shares in 2018Q1 were reported. Old Bank In invested in 76,232 shares or 0.81% of the stock. Mitsubishi Ufj Securities Limited accumulated 0.01% or 10 shares. 13,915 are held by Highland Capital Mgmt Limited Partnership. Northeast Consultants Incorporated invested in 1,000 shares. Long Road Inv Counsel Ltd accumulated 1.93% or 13,160 shares. Moreover, Sta Wealth Management Ltd Liability has 0.11% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 1,649 shares. Moreover, Klingenstein Fields & Co Ltd Liability Co has 1.16% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Tocqueville Asset Mgmt Ltd Partnership accumulated 156,645 shares. Cardinal Capital Mgmt reported 0% stake. Burt Wealth reported 261 shares. 1,500 were accumulated by Asset Advisors Corporation. Cornerstone Advsr owns 249 shares. Rothschild Il reported 55,747 shares. Wellington Mngmt Group Llp holds 0.47% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 10.10 million shares. Washington holds 181,713 shares or 2.02% of its portfolio.

Since June 4, 2018, it had 0 insider buys, and 4 insider sales for $52.76 million activity. Williamson Stephen sold $530,000 worth of stock or 2,500 shares. The insider Jacks Tyler sold 4,772 shares worth $1.14 million.

Pictet Asset Management Ltd increased its stake in Thermo Fisher Scientific Inc (TMO) by 4.92% based on its latest 2018Q2 regulatory filing with the SEC. Pictet Asset Management Ltd bought 142,311 shares as the company’s stock rose 10.49% with the market. The institutional investor held 3.03M shares of the industrial machinery and components company at the end of 2018Q2, valued at $628.39M, up from 2.89M at the end of the previous reported quarter. Pictet Asset Management Ltd who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $100.46B market cap company. The stock increased 0.39% or $0.98 during the last trading session, reaching $249.55. About 2.20 million shares traded or 35.95% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.20% since December 2, 2017 and is uptrending. It has outperformed by 7.58% the S&P500.

Pictet Asset Management Ltd, which manages about $41.81B US Long portfolio, decreased its stake in Weyerhaeuser Co (NYSE:WY) by 142,778 shares to 3.09M shares, valued at $112.50M in 2018Q2, according to the filing. It also reduced its holding in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 109,322 shares in the quarter, leaving it with 412,670 shares, and cut its stake in Fortive Corp.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Arena Pharmaceuticals Is Speculative – Cramer’s Lightning Round (11/15/18) – Seeking Alpha” on November 16, 2018, also Seekingalpha.com with their article: “Thermo Fisher Scientific declares $0.17 dividend – Seeking Alpha” published on November 08, 2018, Bizjournals.com published: “These Mass. life sciences companies are investing the most in R&D – Boston Business Journal” on November 08, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Fool.com and their article: “Becton, Dickinson Closes Out Its Fiscal Year With a Bang – The Motley Fool” published on November 12, 2018 as well as Seekingalpha.com‘s news article titled: “Emerson Electric Is A Great Industrial Stock – Cramer’s Lightning Round (11/8/18) – Seeking Alpha” with publication date: November 09, 2018.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 6 analysts covering Thermo Fisher Scientific (NYSE:TMO), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Thermo Fisher Scientific has $280 highest and $233 lowest target. $246.40’s average target is -1.26% below currents $249.55 stock price. Thermo Fisher Scientific had 9 analyst reports since July 13, 2018 according to SRatingsIntel. Goldman Sachs downgraded the stock to “Neutral” rating in Monday, September 17 report. The stock has “Overweight” rating by Morgan Stanley on Thursday, July 26. Morgan Stanley maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Thursday, October 25 with “Overweight” rating. The firm earned “Overweight” rating on Monday, September 24 by Barclays Capital. Cleveland downgraded the shares of TMO in report on Thursday, October 18 to “Neutral” rating. Citigroup maintained the stock with “Buy” rating in Wednesday, October 10 report. Morgan Stanley maintained the stock with “Overweight” rating in Friday, July 13 report. The company was maintained on Wednesday, October 10 by Morgan Stanley. The rating was maintained by Robert W. Baird with “Outperform” on Thursday, October 25.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.